Barclays 2010 Annual Report Download - page 179

Group Chairman, Deputy Chairman and non-executive Directors
The Group Chairman, Deputy Chairman and non-executive Directors
receive fees which reflect the individual responsibilities and membership
of Board Committees. Fees are reviewed each year by the Board. Fees
were last increased in June 2008.
The first £20,000 of each non-executive Director’s base fee and the
Deputy Chairman’s fee is used to purchase Barclays shares. These Barclays
shares, together with reinvested dividends, are retained on behalf of the
non-executive Directors until they retire from the Board.
Marcus Agius, Group Chairman, has a minimum time commitment to
Barclays equivalent to 60% of a full-time role and he receives private health
insurance in addition to his fees. Marcus Agius is not eligible to receive a
performance incentive, nor participate in Barclays share plans or long term
incentive plans nor will he participate in Barclays pension plans or receive
any pension contributions. No other non-executive Director receives any
benefits from Barclays.
Membership and Chairmanship of Board Committees as at 31st December
2010 and details of the fees received by the non-executive Directors during
the year are set out in Table 14. Details of non-executive Director beneficial
interests in Barclays shares are set out in Table 15.
Table 14: 2010 fees
Chairman
£000
Deputy
Chairman
£000
Board
Member
£000
Board
Audit
Committee
£000
Board
Remuneration
Committee
£000
Board
Corporate
Governance
and
Nominations
Committee
£000
Board Risk
Committee
£000
Benefits
£000
Total
2010
£000
Total
2009
£000
Fees (at 31st Dec 10)
Full-year fee 750 200 70 – – – – – ––
Committee Chair – – – 60 40 – 40 – ––
Committee Member – – – 25 15 15 15 – ––
Fees to 31st December 2010
Group Chairman
Marcus Agius Ch. – – – M. Ch. – 1 751 751
Non-executive Directors
David Booth – – M. – – M. Ch. – 125 85
Sir Richard Broadbent – DCh. M. – Ch. M. – – 200 197
Alison Carnwath – – M. M. M. – – – 39 –
Fulvio Conti – – M. M. – – – – 95 95
Simon Fraser – – M. M. M. – – – 110 83
Reuben Jeffery III – – M. – – – M. – 85 32
Sir Andrew Likierman – – M. M. – – M. – 110 110
Dambisa Moyo – – M. – – – M. – 50 –
Sir Michael Rake – – M. Ch. – M. M. – 160 141
Sir John Sunderland – – M. – M. M. – – 115 108
As Deputy Chairman, Sir Richard Broadbent receives a fee of £200,000 per annum. He does not receive any additional fees for serving on Board Committees or as Senior Independent Director.
Sir John Sunderland is also a member of the Group Brand and Reputation Committee and receives a fee of £15,000 per annum. He was appointed as a member of the Group Brand and
Reputation Committee with effect from 1st July 2009 and received fees of £7,500 in 2009. These fees are included in those shown above.
Table 15: Interests in Barclays PLC shares
At
1st January
2010 total
beneficial
interests
At 31st
December
2010
total
beneficial
interests
At 4th
March
2011 total
beneficial
interests
Group Chairman
Marcus Agius 113,530 115,129 115,129
Non-executive Directors
David Booth 73,325 77,285 79,220
Sir Richard Broadbent 34,590 38,777 40,729
Alison Carnwath –40,000 41,203
Fulvio Conti 39,304 42,970 44,836
Simon Fraser 46,247 49,768 51,583
Reuben Jeffery III 26,173 65,244 67,691
Sir Andrew Likierman 23,007 27,031 29,001
Dambisa Moyo –2,826 4,630
Sir Michael Rake 15,127 18,954 20,845
Sir John Sunderland 79,775 83,277 85,107
Dambisa Moyo was appointed as a non-executive Director with effect from 1st May 2010.
Alison Carnwath was appointed as a non-executive Director with effect from 1st August
2010. Reuben Jeffery's beneficial interest as at 31st December 2010 comprised 15,000
American Depositary Shares and 5,244 Barclays PLC shares. On 15th February 2011, the
non-executive Directors acquired ordinary shares pursuant to arrangements under which
part of each non-executive Director’s fee is used to buy Barclays PLC shares. Barclays PLC
shares were acquired by each non-executive Director as follows: David Booth – 1,935; Sir
Richard Broadbent – 1,952; Alison Carnwath – 1,203; Fulvio Conti – 1,866; Simon Fraser –
1,815; Reuben Jeffery III – 2,447; Sir Andrew Likierman – 1,970; Dambisa Moyo – 1,804;
Sir Michael Rake – 1,891 and Sir John Sunderland – 1,830. Reuben Jeffery's beneficial interest
as at 15th February 2011 comprised 15,000 American Depositary Shares and 7,691 Barclays
PLC shares. Except as described in this note, there were no changes to the beneficial or
non-beneficial interests of non-executive Directors in the period 31st December 2010 to
4th March 2011.
Barclays PLC Annual Report 2010 www.barclays.com/annualreport10 177
Strategy Performance Financial statements Shareholder informationRisk management and governanceAbout Barclays